Rep. Jason DeWitt

Maddy summaryHB 443 amends civil procedure related to notifications in "delictual actions," which are civil lawsuits involving harm or damage. The bill requires a plaintiff's attorney to notify the defendant in writing if the defendant has insurance that may cover a portion of the damages. This notification must be provided within twenty business days of the plaintiff's counsel being retained. This new requirement affects plaintiffs' attorneys by adding a specific notification duty and defendants by ensuring they are informed about their potential insurance coverage early in the legal process.

Maddy summaryHB 440, as amended, addresses insurance claims and the recovery process for claimants. The bill establishes new proceedings that specifically consider a claimant's failure to use their personal health insurance to mitigate damages. It also removes certain provisions related to subrogation concerning insurance payments. This legislation directly impacts individuals making insurance claims and the insurance companies involved in those claims.

Maddy summaryThis concurrent resolution designates the town of Ball, Louisiana, as the official Moon Pie Capital of Louisiana. This honorary title recognizes the town's hosting of its annual Moon Pie Festival.

Maddy summaryHR 20 is a resolution that expresses the condolences of the House of Representatives upon the death of Steven "Steve" Joseph Miguez. It acknowledges his life, business career, competitive shooting achievements, and family.

Maddy summaryHB 414 would exempt up to $25,000 annually of overtime pay and tips from state income tax. This policy directly affects workers in jobs like hospitality, retail, or service industries who earn significant overtime or tip income. The bill sets a clear annual cap: only the first $25,000 of qualifying overtime or tip earnings would be tax-free, with any amount above that remaining taxable. Currently, the bill is under review by the Committee on Ways and Means.

Maddy summaryHB 5 requires Louisiana public school systems to use savings from the Teachers' Retirement System to provide permanent salary increases for teachers and other school employees starting in the 2025-2026 school year. Certificated staff, such as teachers and administrators, must receive at least a $2,000 raise, while non-certificated staff, including aides and clerical workers, must receive at least $1,000. The bill mandates that these salary increases include associated retirement costs and applies to employees on specific leaves, such as military or maternity leave, provided they remain in their approved positions. If a school district does not have enough savings to cover the full amount of these raises, the remaining cost is to be funded through the state's minimum foundation program formula. Additionally, the legislation clarifies that charter schools participating in the state retirement system must also comply with these salary increase requirements.

Maddy summaryThis bill amends existing laws regarding pharmaceutical reimbursements to apply only to contracted pharmacists or pharmacies that do not own more than five shares or a five percent interest in a pharmaceutical wholesale group purchasing organization or vendor. The key provision restricts the scope of the reimbursement rules to ensure they target independent pharmacies rather than those with significant ownership stakes in drug supply chains. By adding this specific limitation, the legislation clarifies which entities must comply with the current reimbursement requirements without changing the underlying financial mechanisms.

Maddy summaryThis Louisiana bill adds Tianeptine, a substance increasingly used for its sedative effects, to Schedule I of the state's Uniform Controlled Dangerous Substances Law. By placing it in this category, the legislation classifies Tianeptine as having a high potential for abuse and no currently accepted medical use within the state. The law applies to any material containing Tianeptine, including its salts and isomers, unless it is part of a product approved by the U.S. Food and Drug Administration. Consequently, this change subjects the substance to the strictest level of regulation, making possession, distribution, and use subject to criminal penalties similar to those for other Schedule I drugs.